CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
Home/Biomarker

MET exon 14 skipping

Gene: MET · Type: mutation

Indications: Non-small cell lung cancer

SensitivityResistanceCIViC Context

FDA Sensitivity Assertions

DrugIndicationRecommendationFDA SourceLink
CapmatinibNon-small cell lung cancerINDICATED
FDA Label
Label
TepotinibNon-small cell lung cancerINDICATED
FDA Label
Label